Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4

Abstract Alteration or abnormal activation of RTKs have been recurrently observed and recognized as an important driving factor in the progression of many human cancers. Ferroptosis, an iron-dependent form of regulated necrosis triggered by the accumulation of lethal lipid peroxides on cell membrane...

Full description

Saved in:
Bibliographic Details
Main Authors: Na Sun, Jiawa Wang, Jianhua Qin, Shuang Ma, Jing Luan, Guoyuan Hou, Wei Zhang, Minghui Gao
Format: Article
Language:English
Published: Nature Publishing Group 2024-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07254-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147332882563072
author Na Sun
Jiawa Wang
Jianhua Qin
Shuang Ma
Jing Luan
Guoyuan Hou
Wei Zhang
Minghui Gao
author_facet Na Sun
Jiawa Wang
Jianhua Qin
Shuang Ma
Jing Luan
Guoyuan Hou
Wei Zhang
Minghui Gao
author_sort Na Sun
collection DOAJ
description Abstract Alteration or abnormal activation of RTKs have been recurrently observed and recognized as an important driving factor in the progression of many human cancers. Ferroptosis, an iron-dependent form of regulated necrosis triggered by the accumulation of lethal lipid peroxides on cell membranes, has been implicated in various tumor types. Here we reported that oncogenic RTKs/RAS/RAF/c-Myc axis promotes cancer cells to ferroptosis. Mechanistically, c-Myc binds to the promoter region of ACSL4 and promotes the expression of ACSL4, thereby sensitizes cells to ferroptosis. We further showed that RTKs/RAS/RAF promote ferroptosis by upregulating c-Myc mediated expression of ACSL4 in cancer cells. Notably, overexpression of RTKs enhances the vulnerability of melanoma to the ferroptosis inducer in mouse xenograft model. These findings may provide an attractive intervention strategy to target cancers with oncogenic activation of RTKs via a ferroptosis-inducing approach.
format Article
id doaj-art-1313b8a1752c44a1a83a8378750a7ece
institution Kabale University
issn 2041-4889
language English
publishDate 2024-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-1313b8a1752c44a1a83a8378750a7ece2024-12-01T12:47:31ZengNature Publishing GroupCell Death and Disease2041-48892024-11-01151111110.1038/s41419-024-07254-9Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4Na Sun0Jiawa Wang1Jianhua Qin2Shuang Ma3Jing Luan4Guoyuan Hou5Wei Zhang6Minghui Gao7The HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyDepartment of Microbiology and Immunology, Weill Cornell MedicineThe HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of TechnologyAbstract Alteration or abnormal activation of RTKs have been recurrently observed and recognized as an important driving factor in the progression of many human cancers. Ferroptosis, an iron-dependent form of regulated necrosis triggered by the accumulation of lethal lipid peroxides on cell membranes, has been implicated in various tumor types. Here we reported that oncogenic RTKs/RAS/RAF/c-Myc axis promotes cancer cells to ferroptosis. Mechanistically, c-Myc binds to the promoter region of ACSL4 and promotes the expression of ACSL4, thereby sensitizes cells to ferroptosis. We further showed that RTKs/RAS/RAF promote ferroptosis by upregulating c-Myc mediated expression of ACSL4 in cancer cells. Notably, overexpression of RTKs enhances the vulnerability of melanoma to the ferroptosis inducer in mouse xenograft model. These findings may provide an attractive intervention strategy to target cancers with oncogenic activation of RTKs via a ferroptosis-inducing approach.https://doi.org/10.1038/s41419-024-07254-9
spellingShingle Na Sun
Jiawa Wang
Jianhua Qin
Shuang Ma
Jing Luan
Guoyuan Hou
Wei Zhang
Minghui Gao
Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
Cell Death and Disease
title Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
title_full Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
title_fullStr Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
title_full_unstemmed Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
title_short Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4
title_sort oncogenic rtks sensitize cancer cells to ferroptosis via c myc mediated upregulation of acsl4
url https://doi.org/10.1038/s41419-024-07254-9
work_keys_str_mv AT nasun oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT jiawawang oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT jianhuaqin oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT shuangma oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT jingluan oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT guoyuanhou oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT weizhang oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4
AT minghuigao oncogenicrtkssensitizecancercellstoferroptosisviacmycmediatedupregulationofacsl4